Stay updated on REL-1017 Monotherapy for MDD Clinical Trial
Sign up to get notified when there's something new on the REL-1017 Monotherapy for MDD Clinical Trial page.

Latest updates to the REL-1017 Monotherapy for MDD Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedAdded a new Revision: v3.3.3 tag to the page. Removed the HHS Vulnerability Disclosure link and Revision: v3.3.2 from the footer.SummaryDifference0.2%

- Check26 days agoNo Change Detected
- Check47 days agoChange DetectedThe study record history now includes Revision: v3.3.2 and removes Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check54 days agoChange DetectedThe notice about government funding and operating status was removed. This removal does not alter the clinical trial data or records shown.SummaryDifference0.8%

- Check69 days agoChange DetectedThe latest version updates the study status and related sections in the record history. It includes changes to Eligibility, Outcome Measures, and Adverse Events reflecting new information about the trial.SummaryDifference0.1%

- Check97 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference12%

- Check104 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.3%

Stay in the know with updates to REL-1017 Monotherapy for MDD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the REL-1017 Monotherapy for MDD Clinical Trial page.